AWcorna, China’s first mRNA vaccine, has been developed by  Abogen Biosciences, Walvax Biotechnology, and the Academy of Military Medical Sciences. Photo:  AP
AWcorna, China’s first mRNA vaccine, has been developed by Abogen Biosciences, Walvax Biotechnology, and the Academy of Military Medical Sciences. Photo: AP

Chinese mRNA booster fights Omicron 4 times better than inactivated Covid-19 vaccines, researchers say

  • AWcorna vaccine produced 4.4 times more Omicron antibodies than Sinovac booster, scientists behind clinical trial write in Cell Research journal
  • Home-grown mRNA jab could be China’s best bet against the highly transmissible variant, with Pfizer-BioNTech’s version yet to clear regulatory hurdle

AWcorna, China’s first mRNA vaccine, has been developed by  Abogen Biosciences, Walvax Biotechnology, and the Academy of Military Medical Sciences. Photo:  AP
AWcorna, China’s first mRNA vaccine, has been developed by Abogen Biosciences, Walvax Biotechnology, and the Academy of Military Medical Sciences. Photo: AP
READ FULL ARTICLE